MyrtiPRO® (BGG Bilberry Extract, Vaccinium myrtillus)

Vaccinium myrtillus
Evidence Level
Limited
2 Clinical Trials
6 Documented Benefits
2/5 Evidence Score

MyrtiPRO® is a bilberry extract (Vaccinium myrtillus) made by BGG from berries hand-picked in northern Sweden and Finland. BGG's published specification is 32.4 to 39.6% anthocyanins by HPLC (its product text separately states at least 36%), equivalent to 25% anthocyanidins by the single-wavelength UV assay, with free anthocyanidins at 1% or less. One randomized, double-blind, placebo-controlled trial has tested this extract on its own: 32 Japanese office workers took a capsule supplying 43.2 mg of bilberry anthocyanins a day for 6 weeks, and pupil response after screen work favoured the bilberry group (p = 0.043) in an additional analysis of individual eyes rather than of whole participants. That trial was funded by BGG Japan, and the paper itself does not name the product; BGG's own announcement identifies the extract as MyrtiPRO. Other bilberry extracts from other suppliers have shown similar effects on focusing and eye strain during screen work, and those trials were also paid for by the companies selling the extract. Controlled trials of bilberry for night vision have been negative, and a randomized trial of bilberry extract found no effect on blood pressure, blood lipids or antioxidant status.

Studied Dose 43.2 mg of bilberry anthocyanins a day (about 120 mg of extract) in the one trial; BGG's own 160 to 320 mg/day is a supplier recommendation, not a tested dose.
Active Compound Bilberry anthocyanins, standardized by BGG to 32.4 to 39.6% by HPLC (also stated at least 36%), equal to 25% anthocyanidins by single-wavelength UV assay, free anthocyanidins 1% or less.

Benefits

Circulation: Not Tested in Modern Trials

The circulation claim for bilberry traces back to a 1972 controlled trial in varicose veins and to studies of capillary permeability in diabetic rats. No modern randomized trial has tested this extract, or any bilberry extract on its own at these doses, on human circulation. A 4-week randomized crossover trial giving 20 adults with type 2 diabetes 1.4 g a day of bilberry extract found no effect on blood pressure or blood lipids.

Focusing and Eye Strain After Screen Work

Randomized trials of bilberry extract in office workers report better pupil response, better flicker fusion and less eye strain after screen sessions: a capsule supplying 43.2 mg of bilberry anthocyanins daily for 6 weeks in 32 adults, 240 mg a day of a different Japanese bilberry extract for 12 weeks in 109 adults, and 480 mg a day of another bilberry extract for 8 weeks in 88 adults. All three were paid for by the company selling the extract tested, and in the smallest of them the significant result came from an analysis of individual eyes rather than of whole participants. No trial of bilberry has measured retinal blood flow or oxygen delivery in people.

Night Vision and Contrast Sensitivity: Controlled Trials Were Negative

A systematic review of placebo-controlled trials found that the four most recent randomized trials of bilberry anthocyanosides for night vision were all negative, and concluded that the hypothesis that bilberry improves normal night vision is not supported by evidence from rigorous clinical studies. In one of those trials, 15 young men with good vision took 160 mg of a 25% bilberry extract three times a day for 3 weeks in a crossover design, and there was no change in night visual acuity or night contrast sensitivity. The wartime story about RAF pilots and bilberry jam is not supported by any published trial. Bilberry has not been rigorously tested in people whose night vision is impaired by eye disease.

Dry Eye: Weak Evidence, and It Comes From Other Products

The dry eye evidence comes from other products. A 4-week randomized trial of Mirtoselect, a bilberry extract made by Indena rather than BGG, found tear volume on the Schirmer test improved from baseline in the 11 people taking it while the 10 on placebo did not change, and no direct comparison between the two groups was reported. A 3-month study in 24 adults with severe dry eye gave 600 mg of bilberry extract together with 240 mg of fish oil, used no placebo and no blinding, and reported effect sizes rather than significance tests. The one trial of BGG's own extract measured tear film break-up time and the Schirmer test as secondary outcomes and reported no improvement in either.

Antioxidant Activity in the Lab, Not Shown in People

Bilberry anthocyanins are antioxidants in laboratory assays. When this was tested in people, a randomized crossover trial giving 20 adults with type 2 diabetes 1.4 g a day of bilberry extract for 4 weeks found no change in antioxidant status, oxidative stress markers or inflammatory markers compared with placebo.

BGG Quality Standards

Adulteration is a real problem in this category. An analysis of 14 bilberry extracts and 12 finished bilberry supplements found that about half the extracts differed significantly from authentic bilberry, roughly 60% of extracts and 33% of finished supplements contained less anthocyanin than declared, and the main adulterants were mulberry and chokeberry. A separate analysis at a German university rated 45% of bilberry supplements unacceptable, including products that contained no bilberry at all. In a third case an extract that read 25% anthocyanins on the standard UV assay turned out to be carrying a synthetic red dye that only HPLC could detect. Buying an extract with a published HPLC anthocyanin specification and identity testing, which BGG publishes for MyrtiPRO, is a reasonable response to that. It is a statement about what is in the capsule, not about what the capsule does.

Mechanism of action

1

Anthocyanin Capillary Integrity

Anthocyanins reduced capillary permeability in diabetic rats. This has not been measured in people taking bilberry extract.

2

Retinal Microcirculation

Proposed but not demonstrated. No published trial has measured retinal or ocular blood flow in people taking bilberry extract on its own.

3

Antioxidant Activity

Bilberry fruit contains about 15 distinct anthocyanins, and that profile is what identity testing checks against. They behave as antioxidants in laboratory assays, but blood measures of antioxidant status did not change in a randomized trial of bilberry extract in people.

4

Authenticated Source

BGG publishes an HPLC anthocyanin specification and identity testing for MyrtiPRO. Reported bilberry adulterants are not limited to related species: they include mulberry and chokeberry extracts, other Vaccinium species, elderberry, and at least one case of a synthetic azo dye, amaranth, which passed the standard UV anthocyanin assay and was caught only by HPLC.

Clinical trials

1
Bilberry Extract 480 mg/day for Screen-Related Eye Fatigue (randomized, double-blind, placebo-controlled)
PubMed

Ozawa Y and colleagues, J Nutr Health Aging 2015;19(5):548-54. An 8-week randomized, double-blind, placebo-controlled trial of bilberry extract 480 mg/day in Japanese office workers using video display terminals. The work was conducted by Wakasa Seikatsu Co., Ltd., the company selling the extract, which employs two of the authors. The extract tested was not BGG's.

88 office workers aged 20 to 40 with relatively low critical flicker fusion and near point accommodation, screened from 281 candidates; 43 on bilberry extract and 37 on placebo completed.

The reduction in critical flicker fusion caused by screen work was smaller after 8 weeks on bilberry extract than on placebo (95% CI 0.10 to 1.60, p = 0.023). Near point accommodation did not differ between groups. Five of 18 subjective eye strain symptoms improved more than placebo. No severe adverse events occurred in either group.

2
MyrtiPRO and Pupil Response After Screen Work (one 32-person randomized, double-blind, placebo-controlled trial funded by BGG Japan)
PubMed

Sekikawa T, Kizawa Y, Takeoka A, Sakiyama T, Li Y, Yamada T. Functional Foods in Health and Disease 2021;11(3):116-146. A 6-week randomized, double-blind, placebo-controlled parallel-group trial of a bilberry capsule supplying 43.2 mg of anthocyanins a day, roughly 120 mg of extract at BGG's stated standardization. Supported by BGG Japan Co., Ltd. and Arysta Health and Nutrition Sciences Corp. The paper does not name the product; BGG's own announcement identifies it as MyrtiPRO. The journal is not indexed in PubMed; the paper carries doi 10.31989/ffhd.v11i3.782.

32 healthy Japanese adults with eye fatigue after using video display terminals; 15 per group were included in the efficacy analysis.

In an additional analysis of individual eyes rather than of whole participants, the change in percentage pupillary response before and after screen work favoured the bilberry group (p = 0.043), and a pupillary response and near point measure also favoured it (p = 0.049). Tear film break-up time, Schirmer's test, muscle hardness and subjective symptoms were secondary outcomes and no improvement in them is reported. No adverse events were reported. This is one small trial funded by the ingredient's maker, and it measured no vascular outcome of any kind.

Side effects and drug interactions

Common Potential side effects

Well tolerated in the trials published so far, which ran 4 to 12 weeks in groups of 20 to 109 people. Longer-term safety has not been studied.
Mild GI distress (rare).
Allergic reactions rare.
Pink/blue stool possible (harmless anthocyanin excretion).
Pink/red urine possible at high doses.

Important Drug interactions

Blood thinners: antiplatelet activity of anthocyanins is described in laboratory work and has not been quantified in people taking bilberry extract. Tell your prescriber if you add it.
Blood pressure medicines: a randomized crossover trial of bilberry extract found no effect on blood pressure, so any additive effect is theoretical rather than observed.
Diabetes medicines: in a randomized crossover trial in type 2 diabetes, HbA1c fell 0.31% on bilberry extract, but that change was not significantly different from placebo. Monitoring glucose is sensible if you combine them; expecting a glucose-lowering effect is not.
Pregnancy: eating bilberries as a food is not a concern, but concentrated bilberry extract has not been tested in pregnancy and there is no human safety data behind taking it.
Breastfeeding: there is no human data on concentrated bilberry extract during breastfeeding.

Frequently asked questions about MyrtiPRO® (BGG Bilberry Extract, Vaccinium myrtillus)

What is MyrtiPRO?

MyrtiPRO® is a bilberry extract (Vaccinium myrtillus) made by BGG from berries hand-picked in northern Sweden and Finland. BGG's published specification is 32.4 to 39.

What is MyrtiPRO used for?

MyrtiPRO is researched primarily for Eye Health. The circulation claim for bilberry traces back to a 1972 controlled trial in varicose veins and to studies of capillary permeability in diabetic rats.

What is the recommended dosage of MyrtiPRO?

The clinically studied dose is 43.2 mg of bilberry anthocyanins a day (about 120 mg of extract) in the one trial; BGG's own 160 to 320 mg/day is a supplier recommendation, not a tested dose. Always follow the product label and check with a healthcare provider for personal advice.

Is MyrtiPRO safe, and does it have side effects?

For most healthy adults, MyrtiPRO is well tolerated at studied doses. Reported effects can include: Well tolerated in the trials published so far, which ran 4 to 12 weeks in groups of 20 to 109 people. Longer-term safety has not been studied. Mild GI distress (rare). It may also interact with some medications. MyrtiPRO is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does MyrtiPRO interact with any medications?

Possible interactions include: Blood thinners: antiplatelet activity of anthocyanins is described in laboratory work and has not been quantified in people taking bilberry extract. Tell your prescriber if you add it. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for MyrtiPRO?

NutraSmarts rates the evidence for MyrtiPRO as Limited (2 out of 5). It is backed by 2 clinical trials and 13 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(13 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Kosehira M, Machida N, Kitaichi N A 12-Week-Long Intake of Bilberry Extract (Vaccinium myrtillus L.) Improved Objective Findings of Ciliary Muscle Contraction of the Eye: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparison Trial Nutrients. 2020;12(3):600. doi: 10.3390/nu12030600.PubMedUsed to support: Randomized, double-blind, placebo-controlled trial in 109 healthy Japanese adults aged 20 to 60. Participants took 240 mg a day of a standardized bilberry extract, or placebo, for 12 weeks. Tonic accommodation of the ciliary muscle after screen work (HFC-1) was better on bilberry than on placebo at weeks 8 and 12 (p = 0.014 and p = 0.017). This measures the focusing muscle, not the retina, and no retinal outcome was assessed. The extract was made by Omnica Co., Ltd., not BGG; Omnica funded the study and two of the three authors are Omnica employees.
  2. Yu WY, Chan LYL, Chung A, Lee PH, Woo GC Bilberry-containing supplements on severe dry eye disease in young and middle-aged adults: A 3-month pilot analysis Front Nutr. 2023;10:1061818. doi: 10.3389/fnut.2023.1061818.PubMedUsed to support: Three-month study in 24 adults with severe dry eye: 12 given a daily supplement containing 600 mg bilberry extract plus 240 mg of DHA-refined fish oil, and 12 given nothing. Ocular Surface Disease Index scores, non-invasive tear break-up time and phenol red thread values improved in the supplemented group. There was no placebo and no blinding, and the authors report effect sizes rather than significance tests. Because bilberry and fish oil were given together, the result cannot be assigned to bilberry.
  3. Riva A, Togni S, Franceschi F, Kawada S, Inaba Y, Eggenhoffner R, Giacomelli L The effect of a natural, standardized bilberry extract (Mirtoselect®) in dry eye: a randomized, double blinded, placebo-controlled trial Eur Rev Med Pharmacol Sci. 2017;21(10):2518-2525.PubMedUsed to support: Four-week randomized, placebo-controlled trial in 22 people with dry eye symptoms, of whom 21 completed: 11 on Mirtoselect, a standardized bilberry extract manufactured by Indena SpA, and 10 on placebo. Tear volume on Schirmer's test improved from baseline in the bilberry group (p = 0.019) while the placebo group did not change; no direct statistical comparison between the two groups is reported. Blood antioxidant potential also improved from baseline (p = 0.003). The paper additionally reports a bioavailability experiment in rats. The product tested is Indena's, not BGG's, and the paper's lead authors are at Indena SpA.
  4. Szumny D, Kucharska AZ, Czajor K, Bernacka K, Ziólkowska S, Krzyzanowska-Berkowska P, Magdalan J, Misiuk-Hojlo M, Sozanski T, Szelag A Extract from Aronia melanocarpa, Lonicera caerulea, and Vaccinium myrtillus Improves near Visual Acuity in People with Presbyopia Nutrients. 2024;16(7):926. doi: 10.3390/nu16070926.PubMedUsed to support: Randomized, double-blind crossover study in 23 adults over 50 with presbyopia who worked long hours at screens, taking 400 mg twice daily of AKB, a combined extract of chokeberry (Aronia melanocarpa), honeysuckle berry (Lonicera caerulea) and bilberry standardized for anthocyanins and iridoids. Near visual acuity did not change during the first 6 weeks and improved only in the second cycle, in 92.3% of patients; Schirmer test wetting improved in 80% at week 6 and fell to 61.5% later. Results are reported as proportions of patients rather than between-arm comparisons, and the authors call the findings preliminary. Because three plants were given together, no effect can be attributed to bilberry.
  5. de Mello VD, Lankinen MA, Lindstrom J, Puupponen-Pimia R, Laaksonen DE, Pihlajamaki J, et al. Fasting serum hippuric acid is elevated after bilberry (Vaccinium myrtillus) consumption and associates with improvement of fasting glucose levels and insulin secretion in persons at high risk of developing type 2 diabetes Mol Nutr Food Res. 2017;61(9). doi: 10.1002/mnfr.201700019.PubMedUsed to support: Metabolite analysis from an 8-week randomized dietary trial in 47 people with features of metabolic syndrome, 15 of whom ate the equivalent of 400 g of fresh bilberries a day. Fasting serum hippuric acid rose 3.5-fold in the bilberry group only (p = 0.001) and correlated with fasting glucose (r = -0.54) and insulin secretion (r = 0.59), with the associations reproduced in the Finnish Diabetes Prevention Study cohort. Hippuric acid is a marker of polyphenol intake, so this shows the berries were absorbed and metabolized. The study measured no antioxidant status and no vascular outcome, and it used whole berries at food quantities, not a concentrated extract.
  6. Muth ER, Laurent JM, Jasper P The effect of bilberry nutritional supplementation on night visual acuity and contrast sensitivity Altern Med Rev. 2000;5(2):164-73.PubMedUsed to support: Double-blind, placebo-controlled crossover trial in 15 young men with good vision at the Naval Aerospace Medical Research Laboratory. Participants took 160 mg of bilberry extract standardized to 25% anthocyanosides three times a day, 480 mg daily, for 21 days per period with a one-month washout. There was no difference between bilberry and placebo in night visual acuity or night contrast sensitivity at any measurement point. The authors concluded the study casts doubt on bilberry improving night vision at currently recommended doses.
  7. Canter PH, Ernst E Anthocyanosides of Vaccinium myrtillus (bilberry) for night vision--a systematic review of placebo-controlled trials Surv Ophthalmol. 2004;49(1):38-50. doi: 10.1016/j.survophthal.2003.10.006.PubMedUsed to support: Systematic review of 30 trials with outcomes relevant to vision in reduced light, 12 of them placebo-controlled. The four most recent trials were all randomized controlled trials and all were negative in outcome. A fifth randomized trial and seven non-randomized controlled trials reported positive effects. Negative outcome was associated with more rigorous methodology. The authors conclude that the hypothesis that bilberry anthocyanosides improve normal night vision is not supported by evidence from rigorous clinical studies, and note a complete absence of rigorous research in people whose night vision is impaired by eye disease.
  8. Penman KG, Halstead CW, Matthias A, De Voss JJ, Stuthe JM, Bone KM. Bilberry adulteration using the food dye amaranth. J Agric Food Chem. 2006;2006;54(19):7378-82.PubMedUsed to support: Two commercial bilberry extracts were assayed for anthocyanin content. Both read 25% by the usual single-wavelength spectrophotometric method, matching the manufacturers' claims, but HPLC showed that in one extract 9% of the anthocyanins were not from Vaccinium myrtillus. Mass spectrometry and NMR identified the substance as amaranth, a synthetic red azo dye. The authors conclude that a single-wavelength assay cannot detect deliberate adulteration and that HPLC with photodiode array detection is the minimum needed.
  9. Gardana C, Ciappellano S, Marinoni L, Fachechi C, Simonetti P Bilberry adulteration: identification and chemical profiling of anthocyanins by different analytical methods J Agric Food Chem. 2014;62(45):10998-11004. doi: 10.1021/jf504078v.PubMedUsed to support: Fourteen commercial bilberry extracts and 12 finished bilberry supplements were profiled by liquid chromatography with diode array and mass spectrometric detection against authentic bilberry fruit, in which 15 anthocyanins were identified. About half the extracts differed significantly from the reference profile, suggesting adulteration. Roughly 60% of extracts and 33% of finished supplements contained less anthocyanin than declared. The adulterants observed were mainly mulberry and chokeberry extracts.
  10. Ozawa Y, Kawashima M, Inoue S, Inagaki E, Suzuki A, Ooe E, Kobayashi S, Tsubota K Bilberry extract supplementation for preventing eye fatigue in video display terminal workers J Nutr Health Aging. 2015;19(5):548-54. doi: 10.1007/s12603-014-0573-6.PubMedUsed to support: Randomized, double-blind, placebo-controlled trial in 88 Japanese office workers aged 20 to 40, screened from 281 candidates for relatively low critical flicker fusion and near point accommodation, with 43 on bilberry extract 480 mg/day and 37 on placebo completing 8 weeks. The screen-work-induced fall in critical flicker fusion was smaller with bilberry than placebo (95% CI 0.10 to 1.60, p = 0.023), while near point accommodation did not differ. Five of 18 subjective eye strain symptoms improved more than placebo. There were no severe adverse events. The work was conducted by Wakasa Seikatsu Co., Ltd., which employs two of the authors and financially supports two more. The extract tested was that company's product, not BGG's.
  11. Gaspar DP, Lechtenberg M, Hensel A Quality Assessment of Bilberry Fruits (Vaccinium myrtillus) and Bilberry-Containing Dietary Supplements J Agric Food Chem. 2021;69(7):2213-2225. doi: 10.1021/acs.jafc.0c07784.PubMedUsed to support: HPLC fingerprinting of bilberry fruit and bilberry supplements against a quantified reference extract at the University of Munster. Ninety-one percent of dried bilberries were of good overall quality, but 45% of the dietary supplements tested were of unacceptable quality, including bilberry-free products, products nearly free of anthocyanins and tannins, and samples falsified with anthocyanins from other sources. Reported adulterants also include other Vaccinium species and elderberries.
  12. Chan SW, Chu TTW, Choi SW, Benzie IFF, Tomlinson B Impact of short-term bilberry supplementation on glycemic control, cardiovascular disease risk factors, and antioxidant status in Chinese patients with type 2 diabetes Phytother Res. 2021;35(6):3236-3245. doi: 10.1002/ptr.7038 (erratum Phytother Res 2022;36(4):1836).PubMedUsed to support: Randomized, double-blind, placebo-controlled crossover trial in 20 patients with type 2 diabetes given 1.4 g a day of bilberry extract for 4 weeks against matching placebo, with a 6-week washout. There was no effect on body weight, blood pressure or lipid profile. HbA1c fell 0.31% on bilberry but the change was not significantly different from placebo. Antioxidant status, oxidative stress and inflammatory status showed no significant differences across treatments.
  13. Kizawa Y, Sekikawa T, Kageyama M, Tomobe H, Kobashi R, Yamada T Effects of anthocyanin, astaxanthin, and lutein on eye functions: a randomized, double-blind, placebo-controlled study J Clin Biochem Nutr. 2021;69(1):77-90. doi: 10.3164/jcbn.20-149.PubMedUsed to support: Forty-four Japanese adults with eye fatigue after screen work took two capsules daily for 6 weeks or placebo, with 20 per group analysed. Each capsule contained 100 mg of a BGG Japan bilberry extract powder supplying 36 mg of anthocyanins, 60 mg of Haematococcus pluvialis pigment supplying 3 mg of astaxanthin, and 12.5 mg of marigold extract supplying 5 mg of lutein, so the daily dose was 200 mg of bilberry extract, 6 mg of astaxanthin and 10 mg of lutein. The active group showed better pupillary response after screen work and better scores for trouble focusing and for difficulty seeing nearby objects. Tear break-up time, Schirmer's value, macular pigment optical density and muscle hardness did not differ between groups. Because three actives were given together, no result can be attributed to bilberry. Sponsored by BGG Japan Co., Ltd. and DHC Corporation, with authors employed by both.